EYES - セカンド・サイト・メディカル・プロダクト (Second Sight Medical Products Inc.) セカンド・サイト・メディカル・プロダクト

 EYESのチャート


 EYESの企業情報

symbol EYES
会社名 Second Sight Medical Products Inc (セカンド・サイト・メディカル・プロダクト)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Electromedical_Electrotherapeutic Apparatus  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 Second Sight Medical Products Inc. is engaged in developing manufacturing and marketing prosthetic devices that restore vision to blind individuals. The Company''s product the Argus II System treats outer retinal degenerations such as retinitis pigmentosa (RP). The Argus II System provides an artificial form of vision that differs from the vision of people with normal sight. It does not restore normal vision and it does not slow or reverse the progression of the disease. The Company''s Argus II System employs electrical stimulation to bypass degenerated photoreceptor cells and to stimulate remaining viable retinal cells thereby inducing visual perception in blind individuals. The Argus II System works by converting video images captured by a miniature camera housed in a patient''s glasses into a series of small electrical pulses that are transmitted wirelessly to an array of electrodes that are implanted on the surface of the retina.   セカンド・サイト・メディカル・プロダクトは、米国の医療機器会社。目の見えない患者に移植可能な視覚的な人工装具を開発、製造、売買に従事する。製品は、外網膜変性(網膜色素変性症) を治療する 「Argus IIシステム」がある。網膜色素変性症は、米国で10万人を含む推定150万人に影響を与える疾患。   Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California.
本社所在地 12744 San Fernando Road Suite 400 Sylmar CA 91342 USA
代表者氏名 Gregg Williams グレッグウィリアムズ
代表者役職名 Chairman of the Board 取締役会会長
電話番号 +1 818-833-5000
設立年月日 35916
市場名 NASDAQ Small Cap
ipoyear 2014年
従業員数 110人
url www.secondsight.com
nasdaq_url https://www.nasdaq.com/symbol/eyes
adr_tso
EBITDA EBITDA(百万ドル) -31.48900
終値(lastsale) 1.61
時価総額(marketcap) 113183561.89
時価総額 時価総額(百万ドル) 105.30700
売上高 売上高(百万ドル) 7.60200
企業価値(EV) 企業価値(EV)(百万ドル) 97.83100
当期純利益 当期純利益(百万ドル) -31.83900
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Second Sight Medical Products Inc revenues decreased 11% to $2.9M. Net loss increased 23% to $17.7M. Revenues reflect Taiwan segment decrease from $313K to $0K Canada segment decrease from $222K to $0K. Higher net loss reflects Selling and marketing - Balancing value increase of 27% to $5.7M (expense) Clinical and regulatory- Balancing value increase of 97% to $2.4M (expense).

 EYESのテクニカル分析


 EYESのニュース

   Second Sight, Nano Precision complete merger, renaming as Vivani Medical  2022/08/30 10:21:27 Seeking Alpha
Second Sight Medical Products (EYES) said it completed its merger with Nano Precision Medical, and has changed its name to Vivani Medical Inc.The company''s common stock will trade…
   Second Sight Medical sheds ~17% after reverse stock split  2022/08/19 14:34:54 Seeking Alpha
Second Sight Medical Products, Inc. (EYES), a maker of implantable visual prosthetics, dropped ~17% on Friday morning as its shares began trading on a split-adjusted basis following…
   Second Sight Medical Products, Inc. Announces Shareholder Approval for Proposed Merger with Nano Precision Medical, Inc. and other Results of 2022 Annual Meeting  2022/07/29 10:00:00 Wallstreet:Online
Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced results of its annual meeting held on July 27, 2022, where the quorum was present. The formal results of the vote are included in a Current Report on
   Second Sight, Nano Precision complete merger, renaming as Vivani Medical  2022/08/30 10:21:27 Seeking Alpha
Second Sight Medical Products (EYES) said it completed its merger with Nano Precision Medical, and has changed its name to Vivani Medical Inc.The company''s common stock will trade…
   Second Sight Medical sheds ~17% after reverse stock split  2022/08/19 14:34:54 Seeking Alpha
Second Sight Medical Products, Inc. (EYES), a maker of implantable visual prosthetics, dropped ~17% on Friday morning as its shares began trading on a split-adjusted basis following…
   Second Sight Medical Products, Inc. Announces Shareholder Approval for Proposed Merger with Nano Precision Medical, Inc. and other Results of 2022 Annual Meeting  2022/07/29 10:00:00 Wallstreet:Online
Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced results of its annual meeting held on July 27, 2022, where the quorum was present. The formal results of the vote are included in a Current Report on
   Critical Contrast: CONMED (NYSE:CNMD) versus Second Sight Medical Products (NASDAQ:EYES)  2021/12/08 06:40:42 Dakota Financial News
CONMED (NYSE:CNMD) and Second Sight Medical Products (NASDAQ:EYES) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, dividends, valuation and earnings. Analyst Recommendations This is a summary of recent ratings for CONMED and Second Sight Medical []
   Companies - State Street Corp Buys New Shares in Second Sight Medical Products, Inc  2021/12/07 09:17:07 Business Mag
State Street Corp purchased a new stake in shares of Second Sight Medical Products, Inc. in the 2nd quarter, according to the company in its most recent Form 13F filing with
   State Street Corp Buys New Shares in Second Sight Medical Products, Inc. (NASDAQ:EYES)  2021/12/07 09:10:42 ETF Daily News
State Street Corp purchased a new stake in shares of Second Sight Medical Products, Inc. (NASDAQ:EYES) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 92,394 shares of the medical device companys stock, valued at approximately $456,000. State Street Corp owned 0.24% [] The post State Street Corp Buys New Shares in Second Sight Medical Products, Inc. (NASDAQ:EYES) appeared first on ETF Daily News .
   Northern Trust Corp Increases Stock Holdings in Second Sight Medical Products, Inc. (NASDAQ:EYES)  2021/12/06 09:08:42 ETF Daily News
Northern Trust Corp increased its holdings in shares of Second Sight Medical Products, Inc. (NASDAQ:EYES) by 33.7% in the second quarter, according to its most recent filing with the SEC. The fund owned 34,658 shares of the medical device companys stock after acquiring an additional 8,735 shares during the period. Northern Trust Corps holdings in [] The post Northern Trust Corp Increases Stock Holdings in Second Sight Medical Products, Inc. (NASDAQ:EYES) appeared first on ETF Daily News .
   Geode Capital Management LLC Increases Stock Holdings in Second Sight Medical Products, Inc. (NASDAQ:EYES)  2021/11/25 09:12:45 Dakota Financial News
Geode Capital Management LLC grew its position in Second Sight Medical Products, Inc. (NASDAQ:EYES) by 36.5% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 146,527 shares of the medical device companys stock after acquiring an additional 39,151 shares during the quarter. Geode Capital Management []

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 セカンド・サイト・メディカル・プロダクト EYES Second Sight Medical Products Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)